Literature DB >> 11051423

Role of esophageal pH recording in management of chronic laryngitis: an overview.

D G Hanson1, D Conley, J Jiang, P Kahrilas.   

Abstract

Chronic laryngitis typically produces symptoms of frequent throat-clearing, soreness, decreased voice quality with use, nonproductive cough, globus sensation, and odynophagia. The endoscopic laryngeal examination usually demonstrates posterior glottic edema, erythema, and increased vascularity and nodularity. There is increasing support for the hypothesis that reflux of acidic gastric contents is often responsible for the symptoms and findings of chronic laryngitis. Prospective trials of acid suppression therapy demonstrate not only efficacy in symptom reduction, but also objective improvement in measurements of voice quality and mucosal erythema. Although traditionally considered the "gold standard" for diagnosis of reflux causing laryngitis, routine esophageal pH recording may result in false negatives in up to 50% of patients. This may confound the diagnosis of chronic laryngitis and delay treatment. Conversely, a positive study during comprehensive therapy may help identify patients who need additional treatment. A single distal probe is probably insufficient for evaluation of a supraesophageal disorder. Current recommendations for double-probe pH study in the evaluation of chronic laryngitis fall into 2 categories: 1) a double-probe pH study is indicated if there is ongoing moderate-to-severe laryngitis despite antireflux precautions and proton pump inhibitor treatment for at least 6 to 12 weeks; and 2) a double-probe pH study is indicated as a baseline measurement before Nissen or Toupet fundoplication. The pH study would also be indicated in patients who have symptoms after fundoplication. There is clearly much more work to be done on the technical issues of obtaining accurate objective data related to laryngeal acidification. In addition, although acid reflux appears to be causative in many cases of chronic laryngitis, further work is indicated to identify reliable testing methods that will predict treatment success.

Entities:  

Mesh:

Year:  2000        PMID: 11051423     DOI: 10.1177/0003489400109s1002

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol Suppl        ISSN: 0096-8056


  10 in total

1.  Management of patients with coexisting obstructive sleep apnea and laryngopharyngeal reflux disease.

Authors:  A Eryılmaz; L Erişen; U L Demir; F Kasapoglu; O A Ozmen; A Ursavas; M Kıyıcı; I Hızalan
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-17       Impact factor: 2.503

2.  Paroxysmal laryngospasm: a typical but underrecognized supraesophageal manifestation of gastroesophageal reflux?

Authors:  Johan Poelmans; Jan Tack; Louw Feenstra
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

3.  Multidimensional voice analysis of reflux laryngitis patients.

Authors:  Rûta Pribuisienë; Virgilijus Uloza; Viktoras Saferis
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-03-05       Impact factor: 2.503

4.  Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice.

Authors:  Vicente Garrigues; Lirios Gisbert; Guillermo Bastida; Vicente Ortiz; Inmaculada Bau; Pilar Nos; Julio Ponce
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

5.  Is pepsin detected in the saliva of patients who experience pharyngeal reflux?

Authors:  A Printza; M Speletas; S Triaridis; J Wilson
Journal:  Hippokratia       Date:  2007-07       Impact factor: 0.471

6.  [Stenosing gastric laryngitis in infancy].

Authors:  A Hennig; A Neumann; H-J Schultz-Coulon
Journal:  HNO       Date:  2004-04       Impact factor: 1.284

Review 7.  Voice outcomes of laryngopharyngeal reflux treatment: a systematic review of 1483 patients.

Authors:  Jérôme R Lechien; Camille Finck; Pedro Costa de Araujo; Kathy Huet; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-23       Impact factor: 2.503

8.  Label-Free Detection of Salivary Pepsin Using Gold Nanoparticle/Polypyrrole Nanocoral Modified Screen-Printed Electrode.

Authors:  Doyeon Lee; Young Ju Lee; Young-Gyu Eun; Gi-Ja Lee
Journal:  Sensors (Basel)       Date:  2018-05-24       Impact factor: 3.576

Review 9.  Pepsin and Laryngeal and Hypopharyngeal Carcinomas.

Authors:  Cheng-Yi Yin; Sha-Sha Zhang; Jiang-Tao Zhong; Shui-Hong Zhou
Journal:  Clin Exp Otorhinolaryngol       Date:  2020-07-24       Impact factor: 3.372

10.  Comparative study of salivary pH and volume in adults with chronic laryngopharyngitis by gastroesophageal reflux disease before and after treatment.

Authors:  Claudia Alessandra Eckley; Henrique Olival Costa
Journal:  Braz J Otorhinolaryngol       Date:  2006 Jan-Feb
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.